Quantum Innovations, a trailblazing medtech startup based in Warsaw, has successfully raised nearly €10 million (PLN 41 million) in its latest funding round dedicated to advancing cardiac surgery technology. The investment was led by Vinci IQ ASI, a fund managed by Vinci S.A., with participation from existing investor MedTech Holding.
Led by renowned physician and CEO Grzegorz Suwalski, Quantum Innovations specializes in developing cutting-edge sensor technology tailored for monitoring organs during surgeries and transplants. Their flagship product, Heart Sense, enables real-time ECG monitoring directly from a beating heart’s surface, offering unprecedented insights into cardiac function. Additionally, their Heart Guard technology tracks tissue metabolism, crucial for managing cardiac surgery procedures effectively.
“We’re driven by a commitment to innovate and enhance surgical outcomes,” remarked Grzegorz Suwalski. “This funding will propel us forward in deploying our technologies globally, aiming to set new standards in cardiac care.”
Piotr Woliński, President of Vinci S.A., expressed confidence in Quantum Innovations’ potential to transform clinical practices. “Investing in QI aligns with our mission to support sustainable development in medical technologies. Their solutions promise to significantly reduce complications and mortality rates associated with heart surgeries.”
The investment will fund the establishment of a state-of-the-art production line in a clean-room environment, along with regulatory and clinical trials necessary for global expansion. Quantum Innovations aims to leverage this funding to solidify its position as a leader in cardiac surgery technology, driving advancements that benefit patients worldwide.
In summary, Quantum Innovations’ latest funding milestone not only underscores its technological prowess but also reaffirms its dedication to revolutionizing cardiac healthcare through innovative medtech solutions. #MedTech #CardiacSurgery #Innovation
